Clinical Trials for RET-altered Solid Tumors

Find clinical trials for ret-altered solid tumors. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Study of RET Inhibitor TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities

NCT ID: NCT04683250

This clinical trial is studying a new medication called TAS0953/HM06 for patients with advanced solid tumors that have specific changes in the RET gene, which can affect how these cancers grow. The...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +16 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions